Rezultati - Steven M. Devine
- Showing 1 - 20 results of 112
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Stem Cell Mobilization od Michele Cottler‐Fox, Tsvee Lapidot, Isabelle Petit, Órit Kollet, John F. DiPersio, Dan Link, Steven M. Devine
Izdano 2003Revisão -
6
-
7
-
8
-
9
Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma od Steven M. Devine, Neal Flomenberg, David H. Vesole, Jane L. Liesveld, Daniel J. Weisdorf, Karin Badel, Gary Calandra, John F. DiPersio
Izdano 2004Artigo -
10
Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Stud... od Nelli Bejanyan, Daniel J. Weisdorf, Brent R. Logan, Hai-Lin Wang, Steven M. Devine, Marcos de Lima, Donald Bunjes, Mei-Jie Zhang
Izdano 2014Artigo -
11
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation od Yi‐Bin Chen, Nirav N. Shah, Anne S. Renteria, Corey Cutler, Johan Jansson, Mona Akbari, Chunlin Chen, Syed M. Quadri, Andrejus Parfionovas, Steven M. Devine
Izdano 2019Artigo -
12
Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Sti... od David A. Hess, Jesper Bonde, Timothy C. Craft, Louisa Wirthlin, Sarah Hohm, Ryan Lahey, Laura Todt, John F. DiPersio, Steven M. Devine, Jan A. Nolta
Izdano 2007Artigo -
13
Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transpl... od Richard T. Maziarz, Timothy Devos, Carlos Bachier, Steven C. Goldstein, José F. Leis, Steven M. Devine, Gabrielle Meyers, James Gajewski, Johan Maertens, Robert Deans, Wouter van’t Hof, Hillard M. Lazarus
Izdano 2014Artigo -
14
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia od Samantha Jaglowski, Amy S. Ruppert, Nyla A. Heerema, Anissa Bingman, Joseph M. Flynn, Michael R. Grever, Jeffrey A. Jones, Patrick Elder, Steven M. Devine, John C. Byrd, Leslie A. Andritsos
Izdano 2012Artigo -
15
Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Tr... od Carol A. Howard, Marcelo Fernández-Viña, Frederick R. Appelbaum, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Adam Mendizabal, Ginna G. Laport, Marcelo C. Pasquini, Stephen R. Spellman
Izdano 2014Artigo -
16
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia od Steven M. Devine, Ron Hoffman, Amit Verma, Rajul Shah, Basil A. Bradlow, Wendy Stock, Vera Maynard, E Jessop, David Peace, Marianne Huml, Deana Thomason, Yi-Hsiang Chen, Koen van Besien
Izdano 2002Artigo -
17
Clinical impact of<i>ABL1</i>kinase domain mutations and<i>IKZF1</i>deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL):... od Rebecca DeBoer, Gregory Koval, Flora Mulkey, Meir Wetzler, Steven M. Devine, Guido Marcucci, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield, Susan Geyer, Charles G. Mullighan, Wendy Stock
Izdano 2016Artigo -
18
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction od Steven M. Devine, Ravi Vij, Michael P. Rettig, Laura Todt, Kiley McGlauchlen, Nicholas M. Fisher, Hollie Devine, Daniel C. Link, Gary Calandra, Gary Bridger, Peter Westervelt, John F. DiPersio
Izdano 2008Artigo -
19
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia od Alison R. Walker, Hongyan Wang, Katherine Walsh, Bhavana Bhatnagar, Sumithira Vasu, Ramiro Garzon, Renee Canning, Susan M. Geyer, Yue-Zhong Wu, Steven M. Devine, Rebecca B. Klisovic, William Blum, Guido Marcucci
Izdano 2016Artigo -
20
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Mu... od Ginna G. Laport, Juan Wu, Brent R. Logan, Veronika Bachanová, Chitra Hosing, Timothy S. Fenske, Walter Longo, Steven M. Devine, Auayporn Nademanee, Iris D. Gersten, Mary M. Horowitz, Hillard M. Lazarus, Marcie Riches
Izdano 2016Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Transplantation
Biology
Oncology
Immunology
Hematopoietic stem cell transplantation
Genetics
Stem cell
Haematopoiesis
Surgery
Gastroenterology
Leukemia
Chemotherapy
Myeloid leukemia
Graft-versus-host disease
Cancer research
Disease
Hematopoietic cell
Gene
Biochemistry
Cyclophosphamide
Immune system
Cell biology
Bone marrow
Lymphoma
Multiple myeloma
Antigen
Confidence interval
Cumulative incidence